GENE ONLINE|News &
Opinion
Blog

China
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Kinnate Buys Back $24 Million Worth Of Shares From China Venture Kinnjiu
2023-02-22
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
China’s Tenacia Books Marinus For $266 Million To Market Seizure Med
2022-11-20
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
2022-11-08
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
1 2 3 7
LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Scroll to Top